Preview Mode Links will not work in preview mode

JAMA Health Forum Editors' Summary

Jan 14, 2022

Overuse of health care, or providing services of low value or no value, is wasteful, potentially harmful to patients, and a contributor to high US health care costs. Jodi Segal, MD, of the Johns Hopkins University School of Medicine joins JAMA Health Forum Editor John Ayanian and Deputy Editor Melinda Buntin to...


Dec 10, 2021

Cost sharing is particularly burdensome for some Medicare beneficiaries, particularly those with incomes just above the poverty level, those with disabilities, or those who have multiple chronic health conditions. Jeanne Madden, PhD, of the Northeastern University School of Pharmacy, and Eric Roberts, PhD, of...


Nov 5, 2021

There are many actors in the drug supply and distribution system, and little is known about the share of drug expenditures going to each, making it more difficult to rein in costs. JAMA Health Forum Associate Editor, Julie Donohue, PhD, and Deputy Editor, Melinda Buntin, PhD, speak with Neeraj Sood, PhD, lead author in...


Oct 8, 2021

State Medicaid programs are required to cover all drugs approved by the US Food & Drug Administration (FDA), including those that have received accelerated approval from the FDA to treat serious or life-threatening illnesses such as HIV or cancer. These drugs with accelerated approval may be beneficial based...


Sep 3, 2021

We know that the pandemic caused millions of people to lose their jobs, and potentially their job-based insurance, and yet new survey data showed surprisingly small changes in uninsurance rates at the end of 2020. Kate Bundorf, PhD, from the Sanford School of Public Policy at Duke University and Jessica Banthin, PhD, of...